MedPath

Bupropion in the treatment of adult ADHD

Phase 2
Conditions
Disturbance of activity and attention.
Disturbance of activity and attention
Registration Number
IRCT201302201556N51
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria: Diagnosis of ADHD based on DSM-IV ; age between 20-60

Exclusion Criteria

Chronic medical disease including seizure,cardiovascular disease, CVA and organic brain disease;substance abuse or dependence during past six months;nursing or pregnant patients; history of tic disorder; receiving of any psychotropics drugs during past two weeks, mental retardation ; history of suicide attempt, psychosis or aggressiveness; receiving psychotropic drugs; receiving psycho-stimulants or atomoxetine during past three months; bipolar disorder

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath